New Research Highlights the Potential Value of Curcumin in Mesothelioma Treatment, According to Surviving Mesothelioma

Share Article

Scientists say the spice compound killed mesothelioma cells in the lab and extended survival in mice with peritoneal mesothelioma.

Mesothelioma Therapy with Spice Compound

Curcumin in Mesothelioma Treatment

Curcumin in vitro inhibited malignant mesothelioma cells survival in a dose- and time-dependent manner...

Doctors in Italy have released a new study focused on the cancer-fighting properties of curcumin, the chemical that gives turmeric its color and pungent flavor. Surviving Mesothelioma has just published an article on the new research. Click here to read it now.

When cancer researchers at the University of Rome treated several different lines of human and mouse mesothelioma cells with curcumin, they found that the compound triggered cellular death or apoptosis and inhibited normal replication of mesothelioma cells.

“Curcumin in vitro inhibited malignant mesothelioma cells survival in a dose- and time-dependent manner and increased reactive oxygen species’ intracellular production and induced DNA damage,” states principal investigator Dr. Laura Masuelli.

According to the report published in the journal Oncotarget, when curcumin was given to mice with peritoneal mesothelioma, the mice lived longer and experienced fewer new mesothelioma tumors.

“This is the latest in a series of studies on the utility of curcumin in the treatment of mesothelioma and other cancers,” says Alex Strauss, Managing Editor of Surviving Mesothelioma. “It is especially exciting for mesothelioma patients who have so few viable treatment options, especially options that do not cause serious side effects.”

You can read more about the Italian study as well as other recent research on curcumin’s potential in mesothelioma therapy in Spice Compound Extends Mesothelioma Survival in Mice, now available on the Surviving Mesothelioma website.

Masuelli, L, “Curcumin blocks autophagy and activates apoptosis of malignant mesothelioma cell lines and increases the survival of mice intraperitoneally transplanted with a malignant mesothelioma cell line”, January 30, 2017, Oncotarget, Epub ahead of print, https://www.researchgate.net/publication/313238018

For more than a decade, Surviving Mesothelioma has brought readers the most important and groundbreaking news on the causes, diagnosis and treatment of malignant mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for mesothelioma patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Ellis
Cancer Monthy
+1 (919) 570-8595
Email >
Follow us on
Visit website